WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $25.27 and last traded at $25.27, with a volume of 5533 shares changing hands. The stock had previously closed at $24.98.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Strong Buy”.
Check Out Our Latest Analysis on WUXAY
WuXi AppTec Stock Performance
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Recommended Stories
- Five stocks we like better than WuXi AppTec
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
